ISCF from Data to Early Diagnosis & Precision MedicinePosted 29th May 2019
The Industrial Strategy Challenge Fund aims to bring together the UK’s world-leading research with business to meet the major industrial and societal challenges of our time. The Industrial Strategy Challenge Fund provides funding and support to UK businesses and researchers. The fund is part of the UK government’s £4.7 billion increase in research and development over 4 years to 2021. It is designed to ensure that research and innovation take centre stage in the government’s Industrial Strategy.
ISCF from data to early diagnosis and precision medicine
“Identifying a disease early is usually the best way to manage and minimise its effect – but some can take years to present symptoms.
As we come to better understand the characteristics of a disease, health professionals will be supported to diagnose patients earlier and select the right treatment first time.
The challenge will invest up to £210 million to combine research data and evidence from the NHS to create new and improved ways of identifying disease and treatment pathways.”- UKRI
Through the ISCF challenge, the government will fund up to £210 million in industry and research to combine data and real-world evidence from our health service and create new products and services that diagnose diseases earlier and more efficiently.
Funding opportunities will be available to UK based researchers and businesses in three main focus areas of investment.
Three Main Areas of Investment
Whole genome sequencing to enable research- the government will fund a large-scale project to provide data-rich resource and improve understanding of disease processes.
Innovating through data funding- this fund will support companies to leverage data to develop novel diagnostics and therapies and maximise its value.
Centres of excellence- New regional centres of excellence will be created to:
• use digital technologies to advance the analysis of tissue biopsies from patients
• make better use of artificial intelligence and machine learning including in imaging techniques such as MRI scans and ultrasound
• support the development of diagnostic tools for early diagnosis and patient stratification
By focusing the funding opportunities to cover these key areas it enables an improved understanding of a disease and its characteristics, it means that the best treatment for the individual can be selected first time to have a less serious impact on a patient’s quality of life.
Grant Funding Success: Knowledge & Network
There is no substitute for talking to the funders, understanding their drivers and getting a definition of the kind of projects & companies they are looking to award grant funding to. The grant funding landscape is ever-shifting with subtle changes in focus and preferences influenced by macro and micro factors. We will continue to bring insights in an attempt to maximise the chance of securing grant funding for our clients.Back to all posts